Advanced search
Add to list

Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies

(2019) HEPATOLOGY. 70(suppl. 1). p.793A-794A
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Murillo Perez, Carla Fiorella, et al. “Optimising Trial Design in Late-Stage Primary Biliary Cholangitis : Evaluating Options for Composite Clinical Endpoint Studies.” HEPATOLOGY, vol. 70, no. suppl. 1, 2019, pp. 793A-794A.
APA
Murillo Perez, C. F., Lammers, W. J., Floreani, A., Corpechot, C., Van der Meer, A., Gulamhusein, A., … Hansen, B. E. (2019). Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies. In HEPATOLOGY (Vol. 70, pp. 793A-794A). Boston, MA, USA.
Chicago author-date
Murillo Perez, Carla Fiorella, Willem J Lammers, Annarosa Floreani, Christophe Corpechot, Adriaan Van der Meer, Aliya Gulamhusein, Cyriel Ponsioen, et al. 2019. “Optimising Trial Design in Late-Stage Primary Biliary Cholangitis : Evaluating Options for Composite Clinical Endpoint Studies.” In HEPATOLOGY, 70:793A-794A.
Chicago author-date (all authors)
Murillo Perez, Carla Fiorella, Willem J Lammers, Annarosa Floreani, Christophe Corpechot, Adriaan Van der Meer, Aliya Gulamhusein, Cyriel Ponsioen, Marco Carbone, Marlyn J Mayo, Pietro Invernizzi, Pier Maria Battezzati, Keith D Lindor, Frederik Nevens, Kris V Kowdley, Tony Bruns, Andrew L Mason, George N Dalekos, Nikolaos K Gatselis, Douglas Thorburn, Xavier Verhelst, Albert Pares, Palak Trivedi, Harry LA Janssen, Gideon Hirschfield, and Bettina E Hansen. 2019. “Optimising Trial Design in Late-Stage Primary Biliary Cholangitis : Evaluating Options for Composite Clinical Endpoint Studies.” In HEPATOLOGY, 70:793A-794A.
Vancouver
1.
Murillo Perez CF, Lammers WJ, Floreani A, Corpechot C, Van der Meer A, Gulamhusein A, et al. Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies. In: HEPATOLOGY. 2019. p. 793A-794A.
IEEE
[1]
C. F. Murillo Perez et al., “Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies,” in HEPATOLOGY, Boston, MA, USA, 2019, vol. 70, no. suppl. 1, pp. 793A-794A.
@inproceedings{8653986,
  author       = {Murillo Perez, Carla Fiorella and Lammers, Willem J and Floreani, Annarosa and Corpechot, Christophe and Van der Meer, Adriaan and Gulamhusein, Aliya and Ponsioen, Cyriel and Carbone, Marco and Mayo, Marlyn J and Invernizzi, Pietro and Battezzati, Pier Maria and Lindor, Keith D and Nevens, Frederik and Kowdley, Kris V and Bruns, Tony and Mason, Andrew L and Dalekos, George N and Gatselis, Nikolaos K and Thorburn, Douglas and Verhelst, Xavier and Pares, Albert and Trivedi, Palak and Janssen, Harry LA and Hirschfield, Gideon and Hansen, Bettina E},
  booktitle    = {HEPATOLOGY},
  issn         = {0270-9139},
  language     = {eng},
  location     = {Boston, MA, USA},
  number       = {suppl. 1},
  pages        = {793A--794A},
  title        = {Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies},
  volume       = {70},
  year         = {2019},
}

Web of Science
Times cited: